These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34585619)

  • 1. Impact of lifestyle interventions targeting physical exercise and caloric intake on cirrhosis regression in rats.
    Lafoz E; Campreciós G; García-Calderó H; Anton A; Vilaseca M; Ruart M; Guasch E; Garrabou G; Delgado TC; Martínez-Chantar ML; García-Martínez R; Gracia-Sancho J; Hernández-Gea V; García-Pagán JC
    Am J Physiol Gastrointest Liver Physiol; 2021 Dec; 321(6):G603-G616. PubMed ID: 34585619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats.
    Lee KC; Hsu WF; Hsieh YC; Chan CC; Yang YY; Huang YH; Hou MC; Lin HC
    Dig Dis Sci; 2019 Jan; 64(1):102-112. PubMed ID: 30288660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-allyl-glutathione improves experimental liver fibrosis by regulating Kupffer cell activation in rats.
    Takemura S; Azuma H; Osada-Oka M; Kubo S; Shibata T; Minamiyama Y
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G150-G163. PubMed ID: 28971836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats.
    Vilaseca M; García-Calderó H; Lafoz E; Ruart M; López-Sanjurjo CI; Murphy MP; Deulofeu R; Bosch J; Hernández-Gea V; Gracia-Sancho J; García-Pagán JC
    Liver Int; 2017 Jul; 37(7):1002-1012. PubMed ID: 28371136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.
    Fortea JI; Zipprich A; Fernandez-Mena C; Puerto M; Bosoi CR; Almagro J; Hollenbach M; Bañares J; Rodríguez-Sánchez B; Cercenado E; Clément MA; Rose CF; Bañares R; Vaquero J; Ripoll C
    Liver Int; 2018 Jan; 38(1):102-112. PubMed ID: 28665498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease.
    Boyer-Diaz Z; Aristu-Zabalza P; Andrés-Rozas M; Robert C; Ortega-Ribera M; Fernández-Iglesias A; Broqua P; Junien JL; Wettstein G; Bosch J; Gracia-Sancho J
    J Hepatol; 2021 May; 74(5):1188-1199. PubMed ID: 33278455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
    Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
    J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosis.
    Zhang CG; Zhang B; Deng WS; Duan M; Chen W; Wu ZY
    World J Gastroenterol; 2016 May; 22(18):4484-500. PubMed ID: 27182159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats.
    Shirin H; Sharvit E; Aeed H; Gavish D; Bruck R
    World J Gastroenterol; 2013 Jan; 19(2):241-8. PubMed ID: 23345947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
    Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
    Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats.
    Rodríguez-Vilarrupla A; Laviña B; García-Calderó H; Russo L; Rosado E; Roglans N; Bosch J; García-Pagán JC
    J Hepatol; 2012 May; 56(5):1033-1039. PubMed ID: 22245887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
    Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
    World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway.
    Sui M; Jiang X; Chen J; Yang H; Zhu Y
    Biomed Pharmacother; 2018 Oct; 106():125-133. PubMed ID: 29957462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term, Low-Dose Exposure to Microcystin-LR Does not Cause or Increase the Severity of Liver Disease in Rodents.
    Labine M; Gong Y; Minuk GY
    Ann Hepatol; 2017 November-December,; 16(6):959-965. PubMed ID: 29055933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution.
    Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD
    Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
    Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
    Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.
    Klein S; Rick J; Lehmann J; Schierwagen R; Schierwagen IG; Verbeke L; Hittatiya K; Uschner FE; Manekeller S; Strassburg CP; Wagner KU; Sayeski PP; Wolf D; Laleman W; Sauerbruch T; Trebicka J
    Gut; 2017 Jan; 66(1):145-155. PubMed ID: 26385087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamically remodeled hepatic extracellular matrix predicts prognosis of early-stage cirrhosis.
    Wu Y; Cao Y; Xu K; Zhu Y; Qiao Y; Wu Y; Chen J; Li C; Zeng R; Ge G
    Cell Death Dis; 2021 Feb; 12(2):163. PubMed ID: 33558482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of carvedilol versus propranolol on acute and chronic liver toxicity in rats.
    Abdel-Kawy HS
    Drug Chem Toxicol; 2021 Jan; 44(1):101-111. PubMed ID: 30810389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amygdalin inhibits TGFβ1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl
    Wang R; Zhang D; Tang D; Sun K; Peng J; Zhu W; Yin S; Wu Y
    Int Immunopharmacol; 2021 Jan; 90():107151. PubMed ID: 33296784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.